Telix Pharmaceuticals
Australia - BrisbanePharmaceutical
Focus: Telix Pharmaceuticals is a specialty pharmaceutical company focused on radio immunotherapy for oncology and neurology indications. The company is headquartered in Brisbane, Australia with a commercial-stage product (ILLUCCIX) and extensive pipeline of radiopharmaceutical candidates.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Telix Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Telix Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
9 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak9.2yr
FDA-approved lead product with 12+ years of market exclusivity; positions Telix as first-mover in Ga-68 PSMA diagnostic space with strong moat.
Help build intelligence for Telix Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.